|
Market Closed -
Bombay S.E.
06:02:27 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 45.45 INR | -4.92% |
|
-7.24% | -12.73% |
Company Valuation: Caprolactam Chemicals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 66.7 | 150.9 | 218 | 240.8 | 236.9 | 203.1 |
| Change | - | 126.21% | 44.51% | 10.44% | -1.62% | -14.25% |
| Enterprise Value (EV) 1 | 87.79 | 167.2 | 254.1 | 295.4 | 294.7 | 289.6 |
| Change | - | 90.42% | 52% | 16.24% | -0.24% | -1.72% |
| P/E | 7.01x | 23.2x | -17x | 9.45x | 120x | -28.7x |
| PBR | 1.91x | 3.7x | 7.79x | 4.51x | 4.27x | 4.21x |
| PEG | - | -0.7x | 0x | -0x | -1.3x | 0x |
| Capitalization / Revenue | 1.02x | 2.39x | 10.5x | 2.45x | 3.41x | 3.01x |
| EV / Revenue | 1.35x | 2.65x | 12.3x | 3x | 4.24x | 4.3x |
| EV / EBITDA | 3.44x | 7.45x | -151x | 6.32x | 12.6x | 19x |
| EV / EBIT | 5.73x | 14.2x | -21.1x | 8.38x | 38.6x | -448x |
| EV / FCF | 7.89x | - | -17.9x | -11.6x | -155x | -11.4x |
| FCF Yield | 12.7% | - | -5.6% | -8.63% | -0.65% | -8.8% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 2.068 | 1.414 | -2.79 | 5.54 | 0.4291 | -1.541 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 65.13 | 63.09 | 20.69 | 98.42 | 69.57 | 67.4 |
| EBITDA 1 | 25.54 | 22.44 | -1.683 | 46.76 | 23.45 | 15.24 |
| EBIT 1 | 15.31 | 11.79 | -12.03 | 35.23 | 7.624 | -0.647 |
| Net income 1 | 9.511 | 6.506 | -12.82 | 25.48 | 1.974 | -7.087 |
| Net Debt 1 | 21.09 | 16.3 | 36.06 | 54.57 | 57.76 | 86.44 |
| Reference price 2 | 14.50 | 32.80 | 47.40 | 52.35 | 51.50 | 44.16 |
| Nbr of stocks (in thousands) | 4,600 | 4,600 | 4,600 | 4,600 | 4,600 | 4,600 |
| Announcement Date | 9/5/20 | 9/2/21 | 9/3/22 | 9/2/23 | 8/29/24 | 8/20/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.19M | |
| 26.67x | 4.21x | 13.54x | 2.15% | 124B | |
| 15.28x | 5.42x | 35.57x | 2.68% | 51.43B | |
| -4663.51x | 1.34x | 9.46x | 6.51% | 39.31B | |
| 12.39x | 1.2x | 6.84x | 2.47% | 33.9B | |
| 9.69x | 3.13x | 7.23x | 4.59% | 24.68B | |
| 9.24x | 0.88x | 5.45x | 4.33% | 20.6B | |
| 30.23x | 2.65x | 14.39x | 0.39% | 19.4B | |
| 71.07x | 12.73x | 46.59x | 0.07% | 18.9B | |
| 16.35x | - | - | - | 18.01B | |
| Average | -496.95x | 3.95x | 17.38x | 2.9% | 35.02B | |
| Weighted average by Cap. | -503.02x | 3.86x | 16.74x | 2.88% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CAPRO6 Stock
- Valuation Caprolactam Chemicals Limited
Select your edition
All financial news and data tailored to specific country editions
